Literature DB >> 31884648

Bestrophin1: A Gene that Causes Many Diseases.

Joseph J Smith1, Britta Nommiste1, Amanda-Jayne F Carr2.   

Abstract

Bestrophinopathies are a group of clinically distinct inherited retinal dystrophies that lead to the gradual loss of vision in and around the macular area. There are no treatments for patients suffering from bestrophinopathies, and no measures can be taken to prevent visual deterioration in those who have inherited disease-causing mutations. Bestrophinopathies are caused by mutations in the Bestrophin1 gene (BEST1), a protein found exclusively in the retinal pigment epithelial (RPE) cells of the eye. Mutations in BEST1 affect the function of the RPE leading to the death of overlying retinal cells and subsequent vision loss. The pathogenic mechanisms arising from BEST1 mutations are still not fully understood, and it is not clear how mutations in BEST1 lead to diseases with distinct clinical features. This chapter discusses BEST1, the use of model systems to investigate the effects of mutations and the potential to investigate individual bestrophinopathies using induced pluripotent stem cells.

Entities:  

Keywords:  BEST1; Bestrophinopathies; Induced pluripotent stem cells; Macula; RPE

Mesh:

Substances:

Year:  2019        PMID: 31884648     DOI: 10.1007/978-3-030-27378-1_69

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Novel mutations in the BEST1 gene cause distinct retinopathies in two Chinese families.

Authors:  Zhi-Hong Zhu; Xin Jin; Yi-Xin Zhang; Rui Wang; Tong Wu; Wei Liu; Ze-Hua Chen; Hai-Nan Xie; Lan-Lan Chen; Zi-Hao Liu; Hou-Bin Huang
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

2.  Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.

Authors:  Arnau Navinés-Ferrer; Sheila Ruiz-Nogales; Rafael Navarro; Esther Pomares
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.